SleepX Ltd. completed the acquisition of AppYea, Inc. in a reverse merger transaction.
May 09, 2022
Share
SleepX Ltd. entered into an agreement to acquire AppYea, Inc. (OTCPK:APYP) in a reverse merger transaction on August 2, 2021. As per the terms of the transaction, the outstanding equity capital consisting of 1,724 common shares of SleepX shall be exchanged for 174 million shares of common stock of AppYea. Post deal completion, SleepX shall own 80% stake in AppYea. As of December 31, 2021, the terms of the agreement were fulfilled.
SleepX Ltd. completed the acquisition of AppYea, Inc. (OTCPK:APYP) in a reverse merger transaction on December 31, 2021.
AppYea, Inc. is a digital health company, which is focused on the development of accurate wearable monitoring solutions to treat sleep apnea and snoring and fundamentally improve quality of life. The Companyâs business plan focuses on two principal devices and an App in development: DreamIT and DreamIT PRO, and SleepX PRO. DreamIT is a biofeedback snoring treatment wristband, combined with the SleepX App and this wristband uses algorithms designed by SleepX combined with sensors to monitor physiological parameters during sleep. DreamIT PRO is a wristband for the treatment of sleep apnea using biofeedback in combination with the SleepX PRO app. The algorithms of SleepX PRO, combined with the wristband sensors, monitor sleep apnea events and additional physiological parameters during sleep, and when necessary. SleepX PRO is a medical application that is used to monitor breathing patterns in sleep and identify sleep apnea episodes without direct contact with the user.
APPYEA, INC. 